SI-BONE, Inc. (NASDAQ:SIBN) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT
Company Participants
Laura Francis – CEO & Director
Anshul Maheshwari – Chief Financial Officer
Presentation
Unknown Analyst
All right. Good morning. Thank you, everybody, for day 2 at the MS Healthcare Conference. I appreciate it. The most exciting are the disclaimers, morganstanley.com/researchdisclosures. I’m sure you’ll all be going there. But what is exciting is having with Laura and Anshul here as CEO and CFO of SI-BONE, respectively. So a beautiful morning. So thanks so much for joining, guys. You got in late last night?
Laura Francis
CEO & Director
Yesterday afternoon, coming in from LSI in London and surgeon dinner last night and meeting with a banker. I think we got done around 11 last night. So…
Question-and-Answer Session
Unknown Analyst
Inevitably, typical. Why don’t we start big picture. The business originally on the sacropelvic joint space, it’s really over the last few years become more of a platform. It might be helpful for you if you could sort of walk through that evolution of that journey and discuss the end markets and products that you’re currently exposed to.
Laura Francis
CEO & Director
Yes. Thanks for the question. And so I’ve been with the company for over 10 years at this point. So started out with the company in 2015. I was the CFO at the time of the company. We’re a private company and really focused very specifically on the SI joint, the largest joint in the human body. It was what we call the last joint in the human body because there was no surgical solution for that largest joint.
So what I think today is quite obvious at the time wasn’t. So we established ourselves as a company that can actually
